GRI Bio OverviewGRI Bio's common stock is $0.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
GRI Bio's common stock stands at $0 as of April 2026. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
GRI Bio reported $0 in common stock versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
In the prior-year period, the figure was $0. Sustained growth in common stock can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.
The history chart shows how GRI Bio's common stock evolved across reporting periods, while the comparison chart places GRI next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, common stock is commonly used to spot outliers. GRI Bio's reading of $0 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
